Compare DHX & RANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DHX | RANI |
|---|---|---|
| Founded | 1991 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 127.3M | 126.8M |
| IPO Year | 2007 | 2021 |
| Metric | DHX | RANI |
|---|---|---|
| Price | $2.40 | $1.31 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | $6.25 | ★ $8.60 |
| AVG Volume (30 Days) | 712.5K | ★ 828.3K |
| Earning Date | 05-06-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 21.05 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $127,826,000.00 | $1,028,000.00 |
| Revenue This Year | N/A | $414.59 |
| Revenue Next Year | $5.20 | $30.15 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.23 | $0.39 |
| 52 Week High | $3.34 | $3.87 |
| Indicator | DHX | RANI |
|---|---|---|
| Relative Strength Index (RSI) | 56.24 | 49.30 |
| Support Level | $1.77 | $0.46 |
| Resistance Level | $2.87 | $1.54 |
| Average True Range (ATR) | 0.33 | 0.10 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 54.70 | 66.67 |
DHI Group Inc is a provider of software products, online tools, and services that deliver career marketplaces to candidates and employers in the United States. The company operates through two reportable segments: ClearanceJobs and Dice. Its brands enable recruiters and hiring managers to search, match, and connect with skilled technologists, particularly in technology and active government security clearance, while professionals find job opportunities, job advice, and personalized data. ClearanceJobs connects security-cleared professionals with employers in a secure environment and supports engagement through messaging and live video. Dice, which generates maximum revenue, is a destination for technology and engineering talent, offering job postings across a range of technology roles.
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.